References
- Mills E, Jadad AR, Ross C, Wilson K. Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination. J Clin Epidemiol 2005; 58:1081-8; PMID:16223649; https://doi.org/10.1016/j.jclinepi.2005.09.002
- Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 2009; 374:2115-22; PMID:19880172; https://doi.org/10.1016/S0140-6736(09)61877-8
- Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med 2013; 369:475-8; PMID:23902490; https://doi.org/10.1056/NEJMsr1302541
- Zarin DA. Participant-level data and the new frontier in trial transparency. N Engl J Med 2013; 369:468-9; PMID:23902488; https://doi.org/10.1056/NEJMe1307268
- Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22; PMID:16394298; https://doi.org/10.1056/NEJMoa052434
- McNicholas A, Galloway Y, Stehr-Green P, Reid S, Radke S, Sexton K, Kieft C, Macdonald C, Neutze J, Drake R, et al. Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004–2006. Hum Vaccines 2007; 3:196-204; PMID:17660718; https://doi.org/10.4161/hv.3.5.4458
- Siegrist CA, Lewis EM, Eskola J, Evans SJ, Black SB. Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions. Pediat Infect Dis J 2007; 26:979-84; PMID:17984802; https://doi.org/10.1097/INF.0b013e318149dfea
- Van Ganse E, Letrilliart L, Borne H, Morand F, Robain M, Siegrist CA. Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination program. Pharmacoepidemiol Drug Saf 2012; 21:261-8
- Clothier HJ, Lee KJ, Sundararajan V, Buttery JP, Crawford NW. Human papillomavirus vaccine in boys: background rates of potential adverse events. Med J Aust 2013; 198:554-8; PMID:23725271; https://doi.org/10.5694/mja12.11751
- Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Thollot F, Garcia-Corbeira P, Damaso S, Han HH, Bouckenooghe A. Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe. Vaccine 2010; 28:5272-9; PMID:20538094; https://doi.org/10.1016/j.vaccine.2010.05.057
- Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98; PMID:20107214; https://doi.org/10.1056/NEJMoa0904797
- Braun MM, Mootrey GT, Salive ME, Chen RT, Ellenberg SS. Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS). Pediatrics 2000; 106:E51; PMID:11015546; https://doi.org/10.1542/peds.106.4.e51
- Al Awaidy S, Bawikar S, Prakash KR, Al Rawahi B, Mohammed AJ. Surveillance of adverse events following immunization: 10/years' experience in Oman. East Mediterr Health J 2010; 16:474-80
- Servicio Nacional de Meteorología e Hidrología del Perú, April 1, 2016, available from: http://www.peruclima.pe/
- Oficina Nacional de Meteorologia Republica Dominicana, April 4, 2016, available from: http://www.onamet.gov.do/
- Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 1990; 131:373-5; PMID:2296988; https://doi.org/10.1093/oxfordjournals.aje.a115507